Información de la revista
Vol. 22. Núm. S2.
16.º Simposio Científico Alimentación, Lípidos y Aterosclerosis
Páginas 25-26 (diciembre 2010)
Vol. 22. Núm. S2.
16.º Simposio Científico Alimentación, Lípidos y Aterosclerosis
Páginas 25-26 (diciembre 2010)
Acceso a texto completo
Familial combined hyperlipidemia: an oligogenic disorder
Visitas
1018
John D. Brunzell
Professor Emeritus-active of Medicine, Medical Director Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
The author apologizes for not using multiple relevant references due to editorial restriction.
[2.]
A.F. Ayyobi, S.H. McGladdery, M.J. McNeely, M.A. Austin, A.G. Motulsky, J.D. Brunzell.
Small, dense LDL (sdLDL) and elevated apo B are the common characteristics for the 3 major lipid phenotypes of FCHL.
Arterio Thromb Vasc Biol, 23 (2003), pp. 1289-1294
[3.]
M.A. Austin, H. Horowitz, E. Wijsman, R. Krauss, J.D. Brunzell.
Bimodality of apolipoprotein B levels in familial combined hyperlipidemia.
Atheroscler, 92 (1992), pp. 67-77
[4.]
G.P. Jarvik, J.D. Brunzell, M.A. Austin, R.M. Krauss, A.G. Motulsky, E. Wijsman.
Genetic predictors of FCHL in four large pedigrees. Influence of apolipoprotein B level major locus predicted genotype and LDL subclass phenotype.
Arterioscler Thromb Vasc Biol, 14 (1994), pp. 1687-1694
[5.]
S.P. Babirak, P.-H. Iverius, W.Y. Fujimoto, J.D. Brunzell.
The detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
Arteriosclerosis, 9 (1989), pp. 326-334
[6.]
S. Babirak, B.G. Brown, J.D. Brunzell.
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Arterio Thromb, 12 (1992), pp. 1176-1183
[7.]
M. Castro Cabezas, T.W. De Bruin, H.W. De Valk, C.C. Shoulders, H. Jansen, W.D. Erkelens.
Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
J Clin Invest, 92 (1993), pp. 160-168
[8.]
J.Q. Purnell, S.E. Kahn, R.S. Schwartz, J.D. Brunzell.
Relationship of insulin sensitivity and apolipoprotein B levels to intraabdominal fat in subjects with familial combined hyperlipidemia.
Arter Thromb Vasc Biol, 21 (2001), pp. 567-572
[9.]
C. Alexander, P. Landsman, S. Teutsch, S. Haffner.
NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
Diabetes, 52 (2003), pp. 1210-1214
[10.]
M.C. Carr, J.D. Brunzell.
Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
J Clin Endocrin Metab, 89 (2004), pp. 2601-2607
[11.]
J.D. Brunzell, J.J. Albers, A. Chait, S.M. Grundy, E. Groszek, G.B. McDonald.
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
J Lipid Res, 24 (1983), pp. 147-155
[12.]
M. Adiels, S.-O. Olofsson, M.-R. Taskinen, J. Boren.
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Arter Thromb Vasc Biol, 28 (2008), pp. 1225-1236
[13.]
M.A. Austin, B. McKnight, K.L. Edwards, C.M. Bradley, M.J. McNeely, B.M. Psaty, et al.
Cardiovascular disease mortality in the familial forms of hypertriglyceridemia: A 20-year prospective study.
Circulation, 101 (2000), pp. 2777-2782
[14.]
B.G. Brown, J.J. Albers, L.D. Fisher, S.M. Schaefer, J.-T. Lin, C. Kaplan, et al.
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
N Engl J Med, 323 (1990), pp. 1289-1298
Copyright © 2010. Sociedad Española de Arteriosclerosis y Elsevier España S.L.